The current GLP-1 medications list includes semaglutide (Ozempic, Wegovy, Rybelsus, and an oral Wegovy pill), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), exenatide (Byetta, Bydureon BCise), and lixisenatide (Adlyxin)
The dual mechanism of tirzepatide has a synergistic impact that is strong enough to significantly lower the risk of cardiovascular events [3, 4]
Combining the contents of two separate, opened vials dramatically increases the risk of cross-contamination
Green Tea and GLP-1 Receptor Function GLP-1 receptor activation depends on proper cellular signaling pathways
Understanding how to manage missed doses, minimise side effects upon resumption, and maintain weight loss during treatment gaps is essential for successful long-term outcomes with this once-weekly subcutaneous medication
Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis